Join to access to all OVN content. Join for Free

Results for 'Early drug access'

...
Partner Avatar MSL Talk: Tom Caravela, Paul Ward
How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes

May 12th • 41 mins read

...
Partner Avatar MSL Talk: Tom Caravela, Jason Demuth
Best Practices and Creative Ways to Gain KOL Access During COVID-19

Oct 13th • 31 mins read

...
Partner Avatar MSL Talk: Tom Caravela, Andrea Johnson
Difficult KOLs: How to overcome challenges, find success and gain access

Aug 30th • 32 mins read

...
Partner Avatar MSL Talk: Tom Caravela, Ruchit Parikh
Market Access and the MSL Role

Jan 10th • 26 mins read

...
Partner Avatar MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World

Dec 10th • 34 mins read

...
Partner Avatar MSL Talk: Tom Caravela, Jeff Vaughn, Dean McAllister
Is it Ever Too Early or Too Late

Feb 18th • 34 mins read

...
OVN Avatar Cancer Buzz Podcast
Increasing Clinical Trial Access for Blood Cancers

Jun 7th • 19 mins read

...
OVN Avatar Cancer Buzz Podcast
Clinical Trial Access in Rural Areas

Oct 16th • 24 mins read

...
OVN Avatar Asco Daily News Podcast
Addressing the Impact of Prior Authorization on Access to Cancer Treatment

Jun 8th • 26 mins read

...
OVN Avatar The Oncology Nursing Podcast
How Washington Is Tackling High Prescription Drug Costs

Feb 16th • 32 mins read

...
OVN Avatar The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development

Oct 16th • 38 mins read

...
OVN Avatar The Oncology Nursing Podcast
Monoclonal Antibodies to Treat Cancer and COVID-19

Jul 15th • 27 mins read

...
OVN Avatar The Oncology Nursing Podcast
Biosimilar Basics for Oncology Nurses and Patients

Feb 1st • 30 mins read

...
OVN Avatar The Oncology Nursing Podcast
Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon

Dec 24th • 46 mins read

...
OVN Avatar The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs

Mar 30th • 53 mins read